Related Experiment Video
Updated: Jun 20, 2025
08:47
Intracranial Injection of Adeno-associated Viral Vectors
Published on: November 17, 2010
47.5K
Microglia targeting by adeno-associated viral vectors
Maria Stamataki1, Björn Rissiek2, Tim Magnus2
1ENDomics Lab, Department of Oncology, Hematology & Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Frontiers in Immunology
|July 22, 2024
Summary
Adeno-associated virus (AAV) methods offer promising avenues for targeting microglia, the brain's immune cells. This review explores AAV-based strategies to precisely modulate microglial function for neurological disorder therapies.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Microglia are central to central nervous system (CNS) homeostasis and neuroinflammation.
- Purinergic signaling molecules critically regulate microglia activation.
- Targeting microglia is key for treating neuroinflammatory disorders, but selective gene function studies are challenging.
Purpose of the Study:
- To review adeno-associated virus (AAV)-based strategies for targeting microglia.
- To discuss prospects for enhancing the specificity and effectiveness of these AAV approaches.
- To encourage research into AAV-mediated microglial targeting for neurological diseases.
Main Methods:
- Review of existing literature on AAV vectors for microglia targeting.
- Analysis of mechanisms controlling microglia activation and response.
- Discussion of challenges and opportunities in AAV-based gene delivery to microglia.
Main Results:
- AAV vectors show potential for specific microglia targeting in the CNS.
- Refinements in AAV design and delivery can improve targeting efficiency.
- Current approaches offer a foundation for developing novel therapeutic strategies.
Conclusions:
- AAV-mediated gene delivery presents a viable tool for modulating microglial activity.
- Further optimization of AAV strategies is needed for clinical translation.
- Targeted microglial modulation holds therapeutic promise for various neurological conditions.
